Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry

BACKGROUND: Since 2015, the European pulmonary hypertension guidelines recommend the use of combination therapy in most patients with pulmonary arterial hypertension (PAH). However, it is unclear to what extent this treatment strategy is adopted in clinical practice and if it is associated with impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeper, Marius M., Pausch, Christine, Grünig, Ekkehard, Staehler, Gerd, Huscher, Doerte, Pittrow, David, Olsson, Karen M., Vizza, Carmine Dario, Gall, Henning, Distler, Oliver, Opitz, Christian, Gibbs, J. Simon R., Delcroix, Marion, Ghofrani, H. Ardeschir, Rosenkranz, Stephan, Park, Da-Hee, Ewert, Ralf, Kaemmerer, Harald, Lange, Tobias J., Kabitz, Hans-Joachim, Skowasch, Dirk, Skride, Andris, Claussen, Martin, Behr, Juergen, Milger, Katrin, Halank, Michael, Wilkens, Heinrike, Seyfarth, Hans-Jürgen, Held, Matthias, Dumitrescu, Daniel, Tsangaris, Iraklis, Vonk-Noordegraaf, Anton, Ulrich, Silvia, Klose, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160392/
https://www.ncbi.nlm.nih.gov/pubmed/34675047
http://dx.doi.org/10.1183/13993003.02024-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160392/
https://www.ncbi.nlm.nih.gov/pubmed/34675047
http://dx.doi.org/10.1183/13993003.02024-2021

Ejemplares similares